ArchiveIn recent years, liposome products have been successively launched. However, standardized testing methods for in vitro release of liposomal products have not been incorporated in various pharmacopoeias, which poses great challenges for the development and regulation of liposomal products. In vitro release is an important technical indicator for evaluating the quality of pharmaceutical preparations, and plays an important role in product development, quality research, and product release. This review introduces the in vitro release methods and detection apparatuses of liposomal products reported both domestically and internationally, and elaborates on the selection basis of in vitro release methods suitable for approval products. It is hoped that this review will promote and improve the development of in vitro release methods for liposomes, and provide more scientific and accurate data support for the research and regulation of liposome products.
Nanocrystal pharmaceutical products can significantly improve drug solubility and bioavailability. Several products have been marketed globally, but domestic and foreign regulatory agencies have not yet formed a clear and unified regulatory assessment program for them. This review introduces the regulation and listing of some nanocrystal pharmaceutical products marketed at home and abroad, discusses the pharmaceutical research and evaluation from the aspects of API, excipients, production process, quality research and control, packaging materials and stability, and analyzes them with case studies, in order to provide a reference for the pharmaceutical research and evaluation of nanocrystal pharmaceutical products.
Fresh Chinese medicinal materials are prone to decay and deterioration due to their high moisture content. Reducing the moisture content through drying process is a common method to extend the shelf life of the herbal materials. However, the drying process of Chinese herbal medicines often takes a long time and causes damage to product quality. Selecting a proper pretreatment technology before drying can not only shorten drying time, but also play a positive role in ensuring the quality of Chinese medicinal materials. This review introduces the mechanism of different drying pretreatment technologies and their impacts on the drying efficiency and quality of Chinese herbal medicines, analyzes the existing problems in the application, and proposes the choices of pretreatment methods for some Chinese herbal medicines with different active ingredients. It is hoped to provide some references for the application of drying pretreatment techniques to Chinese medicinal materials.
One of the crucial steps in preparing a contemporary solid traditional Chinese medicine formulation is drying of the traditional Chinese medicine extracts. However, the drying efficiency of traditional Chinese medicine extract is low, the energy consumption is high, the extract powder has high hygroscopicity and poor fluidity, and prominent problems such as spray drying wall sticking, have plagued the traditional Chinese medicine pharmaceutical industry for a long time. The addition of drying aids is an effective way to solve the above problems and has important applications in the drying of traditional Chinese medicine extracts. This article analyzes and summarizes the role and main applications of drying aids in the drying of traditional Chinese medicine extracts through literature research, and summarizes the drying mechanism of drying aids, in order to provide a reference for improving the drying efficiency and quality of traditional Chinese medicine extracts.
Lactoferrin is a natural glycoprotein that has received extensive attention as a natural biomaterial with targeting functions. Lactoferrin-conjugated drugs or lactoferrin modified nano-based drug delivery systems can effectively deliver antineoplastics to tumor sites through receptor-mediated endocytosis to minimizing side effects and achieving higher therapeutic effects. This review introduces the composition and performance of drug delivery systems designed and developed with lactoferrin as a targeted ligand, with the aim of providing a reference and new ideas for in-depth study of delivery systems of antineoplastics.
The rapid development of inhaled products, especially dry powder for inhalation, highlights the quantitative demands for the amorphous content of micronized bulk drugs. This review briefly describes seven widely used quantitative methods, named PXRD, DSC, dynamic vapor adsorption, microcalorimetry, solution calorimetry, IR and Raman spectroscopy methods, as well as their limitations and corresponding detection instruments. And based on the common limit requirements of amorphous content for inhaled bulk drugs, some examples are provided. The advantages and disadvantages of different methods are analyzed to provide some references for related researches.
Double-layer tablets are a novel dosage form which attract wide attention. With bilayer structures, double-layer tablets can enhance drug efficacy, reduce adverse drug reactions and improve patient compliance by combination medication or adjusting the release rate. This review summarizes the research progress of double-layer tablets in recent years, generalizes the characteristics, preparation methods and classification of double-layer tablets, and introduces its clinical applications with case studies. It is hoped to provide a reference for the research and development of double-layer tablets.
With 3-[(tert-butoxycarbonyl)amino]propanoic acid(2) and 1-(2-methoxyphenyl)piperazine hydrochloride(3) as starting materials, tert-butyl [3-[4-(2-methoxyphenyl)piperazin-1-yl]-3-oxopropyl]carbamate(4)was obtained by active ester method. 3-[4-(2-Methoxyphenyl)piperazin-1-yl]propylamine trihydrochloride(6 hydrochloride) was prepared by the reduction of 4 followed by removing the Boc protective group. Finally, 6 was condensed with 6-chloro-1,3-dimethylpyrimidine-2,4(1H,3H)-dione(7) to obtain the title compound with an overall yield of above 61.2%(based on 2) and a purity of 99.95%. The target product was confirmed by HPLC, 1H NMR, 13C NMR, MS and elemental analysis. The improved process is suitable for industrial production as it solves the technical problem of localization of key intermediate 6.
The synthetic process of zoledronic acid(1) was improved. With commercially available imidazole(3)and ethyl chloroacetate(4) as raw materials, the intermediate imidazol-1-acetic acid hydrochloride(2 hydrochloride)was obtained by N-alkylation and hydrolysis reaction through a “one pot method” under the presence of potassium tert-butanol. Crude 1 was then synthesized from 2 hydrochloride, with phosphorus trichloride as the phosphonation reagent. The yield was raised from 46% to 87% by increasing the amounts of methanesulfonic acid and phosphorus trichloride and prolonging the reaction time. After recrystallization from water and acetone, 1 was obtained in 68% yield(based on 3) with HPLC purity of 100.0%. The improved process has the characteristics of low production cost, safer and simpler operation and high yield, which makes it amenable for industrial production.
An improved synthetic process of zolpidem tartrate(1) was developed. Glyoxylic acid(4)was reacted with acetic anhydride to obtain 2,2-diacetoxyacetic acid(5), which was chlorinated by thionyl chloride to generate 2,2-diacetoxyacetyl chloride(6). Then, 6 reacted with dimethylamine chloride to provide N,N-dimethyl-2,2-diacetoxyacetamide(7). Finally, 7 was hydrolyzed by pyridinium 4-toluenesulfonate to afford the key intermediate N,N-dimethyl-2-oxoacetamide(8). p-Methylacetophenone(2) was another starting material, and brominated with bromine, followed by the reaction with 2-amino-5-methylpyridine by “one-pot” method to synthesize 6-methyl-2-(4-methylphenyl)-imidazole[1,2-a]pyridine (3), which was converted into α-hydroxyzolpidem(9) via nucleophilic addition with 8, and then 9 was subjected to the reduction by chlorotrimethylsilane/NaI system to bring out zolpidem(10). Finally, the target compound 1 was obtained from 10 through salification with L-(+)-tartaric acid with an overall yield of 52.4%(based on 2)and the purity of 99.89%. The process was stable with simple operation and low cost, which was suitable for industrial production.
Methyl 8-chloro-6-oxooctanoate(4) was synthesized by acylating chlorination and Nenitzescu reaction from the commercial available material 6-methoxy-6-oxohexanoic acid(2). Then methyl (E)-8-(1,3-dioxoisoindolin-2-yl)-6-(2-tosylhydrazineylidene)octanoate(6) was obtained by substitution and condensation of 4. Ultimately,8-aminooctanoic acid(1) was obtained by reduction, hydrazolysis and hydrolysis reaction from 6, which was an important starting material for the synthesis of the permeation enhancer sodium N-[8-(2-hydroxybenzoyl)amino]octanoate(SNAC). The total yield of this new synthetic route was 58.9%(based on 2) with the purity of 99.83%. This new process is suitable for industrial production with mild conditions, low raw material cost and simple operations.
In an effort to enhance the solubility and oral absorption of quercetin(1), this study employed microfluidic technology to formulate quercetin nanocrystals(QNCs). The research investigated the influences of 1 solution flow rate, anti-solvent phase flow rate, and 1 concentration on the particle size of QNCs. The QNCs were then characterized by a variety of techniques including TEM, DSC, and PXRD. The findings revealed that the particle size of the QNCs could be effectively managed by adjusting the solution flow rate and 1 concentration through microfluidic technology. The formulated QNCs exhibited an amorphous form with a particle size of (79.23±0.45)nm and a polydispersity index(PDI) of (0.144±0.008). Then, an in vitro dissolution test in pH 7.4 PBS was carried out. In addition, a comparative pharmacokinetic study was conducted in rats, in which either QNCs or bulk quercetin were administered orally. Moreover, the QNCs demonstrated an improved dissolution rate in vitro and superior oral bioavailability compared to the bulk drug. These results suggest that microfluidic technology offers significant potential for improving the bioavailability of drugs with poor solubility.
Levothyroxine sodium(1) is the first choice for hypothyroidism treatment, but its therapeutic window is narrow. In clinical use, it is often necessary to use methods such as grinding and breaking to divide the dose, which may reduce the safety. Therefore, this study prepared 1 3D printing tablets, explored the bioequivalence between the 1 3D printed tablets and the reference preparations, and established the correlation between the in vivo absorption and in vitro drug dissolution of the 1 3D printed tablets. The results showed that 1 3D printed tablets and the reference preparations were bioequivalent, and both pharmacokinetic processes could be described by a one-compartment model. The similarity factor (f2) values of the dissolution curves of both preparations in three dissolution media were all above 50. The fitting result of Class A in vitro-in vivo correlation showed that the in vitro cumulative dissolution rate and the in vivo absorption fraction of the 1 3D printed tablets and the reference formulation measured in three dissolution media had a good correlation. This study provided a reference for the in vitro and in vivo evaluation research of 3D printed tablets.
In this study, a LC-MS/MS analytical method was developed for determination of natamycin(1) to assess its distribution in various ocular tissues of New Zealand white rabbits. The results revealed that , after intravitreal administration of 1 to New Zealand white rabbits, 1 was widely distributed in various ocular tissues, particularly in the posterior segment of the eye. The cmax and AUC0→24 of 1 in retina and vitreous were 46 400 and 4 620 ng/g, 232 000 and 29 300 h·ng·g–1, respectively. The results demonstrated that the 1 amounts were higher in both retina and vitreous than in other ocular tissues. After 24 hours post-dosing, the drug concentration remained high level in all ocular tissues, indicating a longer retention of 1. Given this high specificity and reliable results, this established LC-MS/MS method is suitable for investigating distribution of 1 in ocular tissues and can be used to explore further potential treatments for ocular diseases with 1.
In this study, based on the observation of the activity of both gallic acid and ellagic acid against Helicobacter pylori (H. pylori) in vitro, an orthogonal test was used to optimize the extraction process of Hezi Qingyou formula, with the adding amount of water, extraction time and extraction times as influencing factors, content of gallic acid and ellagic acid and extraction rate as evaluation indexes. And the in vitro inhibitory activity of the aqueous extracts against H. pylori was investigated. The results showed that the optimized extraction process of Hezi Qingyou formula was as follows: adding 10 times amount of water, extraction 1.5 h per time and 2 times of extraction. Under these conditions, the aqueous extracts of Hezi Qingyou formula showed significant in vitro inhibition of H. pylori growth in a concentration-dependent manner, with the MIC of 80 - 160 μg/mL.
Qualitative analysis was performed on the characteristic peaks in the fingerprint of Notopterygii Rhizoma et Radix by HPLC-high-resolution mass spectrometry. Notopterygii Rhizoma et Radix was extracted by methanol with ultrasound, and then the supernatant was centrifuged and filtered before analysis. The electric spray ion source was used in positive and negative ion mode, and data was collected in full scan and data-dependent acquisition(DDA)modes. Then, these data were retrieved using LabSolutions Insight software combined with the ChemSpider database to confirm the elemental compositions and possible structural information on twelve characteristic chromatographic peaks in Notopterygium incisum Ting ex H. T. Chang and Notopterygium franchetii H. de Boiss. Among them, 1,5-O-dicaffeoylquinic acid and praeruptorin B were identified for the first time from Notopterygii Rhizoma et Radix. This study provided a reference for expanding the application of Notopterygii Rhizoma et Radix and improving the overall quality evaluation system of Rhizoma et Radix Notopterygii.
The UPLC fingerprints of Cinnamomi Ramulus and its different parts were established, and the differences of Cinnamomi Ramulus and its different parts were investigated by similarity evaluation, chemical pattern recognition and entropy TOPSIS method. The results showed that six common peaks were determined and five components were identified in the fingerprints of Cinnamomi Ramulus, xylem and phloem. The similarity values of Cinnamomi Ramulus, xylem and phloem in ten batches were all greater than 0.990. The results of variance analysis showed that there were significant differences in six components between xylem and phloem. Cluster analysis and principal component analysis showed that the chemical compositions of Cinnamomi Ramulus were more similar to those of phloem than xylem. The results of orthogonal partial least square discriminant analysis could cluster Cinnamomi Ramulus and its different parts into three categories, which were Cinnamomi Ramulus, xylem and phloem. And cinnamaldehyde was screened as the main variable causing the difference of different parts of Cinnamomi Ramulus. The results of entropy TOPSIS method showed that the Euclid approach degree(Ci) of Cinnamomi Ramulus, xylem and phloem were 0.458, 0.249 and 0.577, respectively. The established method can reflect the differences of Cinnamomi Ramulus, and provide a reference for the quality control of Cinnamomi Ramulus.
By adding different volume fractions of ethanol into 0.1 mol/L hydrochloric acid and increasing the rotational speed, the risk of dose dumping of gliclazide(1) sustained-release tablets (self-made and reference preparations) was evaluated by HPLC, and the detection method was validated . The results showed that the release behavior of the reference preparation and the self-made tablets was basically the same after adding different volume fractions of ethanol in hydrochloric acid and increasing the rotational speed. The similarity factor(f 2) values were all greater than 50, and there was no dose dumping phenomenon. This study also found that 1 degraded very rapidly in the hydrochloric acid containing ethanol, with the degradation rate of about 40% in one hour, resulting in impurity A and impurity C. The impurity contents had far exceeded the acceptable limits specified by the quality standard. It was suggested that when taking the 1 sustained-release tablets, alcohol consumption should be prohibited in order to avoid increasing unknown safety risks due to excessive impurities.
An ICP-MS method was established to determine the contents of eleven elemental impurities, including lead(Pb), cadmium(Cd), mercury(Hg), arsenic(As), cobalt(Co), vanadium(V), nickel(Ni), lithium(Li), antimony(Sb), copper(Cu), and chromium(Cr), in paricalcitol(1). The sample was pretreated by microwave digestion method, with bismuth(Bi), germanium(Ge), and scandium(Sc) as internal standards. The kinetic energy discrimination(KED) collision mode was used, and the sample was injected into a glass concentric atomizer. The radio frequency forward power was 1 300 W, the atomization gas flow rate was 0.8 L/min, the plasma gas flow rate was 15.0 L/min, and the auxiliary gas flow rate was 1.2 L/min. The results showed that it was linear for above eleven elemental impurities in the concentration range of 25% - 200%. The quantification limits were 0.007 - 2.023 ng/mL, the average sample recoveries(n=9) were 86.0% - 104.9%, and RSDs(n=6) in the repeatability test were less than 2.3%. The established method is accurate and highly sensitive, which can be used for the trace control of eleven elemental impurities in 1.
The quality and safety of non-sterile pharmaceutical products are affected by microbial contamination, so the microbial contamination control is an important measure to ensure the safety of pharmaceuticals. Water activity is a key physicochemical parameter that affects the growth and reproduction of microorganisms, and it can be easily, accurately and rapidly determined. Controling the water activity in an appropriate range would help to inhibit the growth and reproduction of microorganisms. This study established a microbial control strategy by determining water activity values of herbs and excipients, intermediate products, and final products of Fengliao Changweikang preparations, and combining with the risk assessment of the production process. This study provided a new idea for the microbial control of non-sterile pharmaceutical products and the development of standards.